National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Understanding Cancer Series: Genetic Variation (SNPs)
< Back to Main
    Posted: 01/28/2005    Reviewed: 09/01/2006
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
View/Print PDF  View/Print PDF
View/Print PowerPoint  View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Office of Biorepositories and Biospecimen Research

The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates
Slide 29 : Smoking and Susceptibility to Lung Cancer - SNPs in Carcinogen-Making Proteins previousnext

Because of SNPs, a person's genome may express a very active carcinogen-making protein, or a sluggish one, or something in between.

A protein with a very active binding site can "grab" more precarcinogen than usual. Or the protein may convert the precarcinogen to the carcinogen at a faster rate. In both cases, more carcinogen molecules pile up in the lungs, causing damage to the cells' DNA, which can lead to cancer.

On the other hand, if the SNPs result in a slow carcinogen-making protein, the lung is exposed to fewer DNA-damaging carcinogens, and the chance of cancer is reduced.

But until the body is exposed to cigarette smoke, no effect is seen.

Smoking and Susceptibility to Lung Cancer - SNPs in Carcinogen-Making Proteins

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov